Sacituzumab Govitecan (IMMU-132), an Anti-Trop-2/SN-38Antibody–Drug Conjugate: Characterization and Efficacy in Pancreatic,Gastric, and Other Cancers.

Autor: Cardillo, Thomas M., Govindan, Serengulam V., Sharkey, Robert M., Trisal, Preeti, Arrojo, Roberto, Donglin Liu, Rossi, Edmund A., Chien-Hsing Chang, Goldenberg, David M.
Zdroj: Bioconjugate Chemistry; May2015, Vol. 26 Issue 5, p919-931, 13p
Databáze: Supplemental Index